{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:52:21Z","timestamp":1790815941765,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI56168, AI100631, AI116420"],"award-info":[{"award-number":["AI56168, AI100631, AI116420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["Merit Review grant I01BX002624"],"award-info":[{"award-number":["Merit Review grant I01BX002624"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153853","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T17:29:41Z","timestamp":1460741381000},"page":"e0153853","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis"],"prefix":"10.1371","volume":"11","author":[{"given":"Visesato","family":"Mor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir M.","family":"Farnoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Rella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"Aids"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","article-title":"Antibodies elicited by a <italic>Cryptococcus neoformans<\/italic>-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection","volume":"165","author":"A Casadevall","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566524054022567","article-title":"Insights into mechanisms of antibody-mediated immunity from studies with <italic>Cryptococcus neoformans<\/italic>","volume":"5","author":"A Casadevall","year":"2005","journal-title":"Current Molecular Medicine"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of <italic>Cryptococcus neoformans<\/italic> in a murine model","volume":"14","author":"SJ Devi","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1567-1364.2006.00073.x","article-title":"Towards a vaccine for <italic>Cryptococcus neoformans<\/italic>: principles and caveats","volume":"6","author":"K Datta","year":"2006","journal-title":"FEMS Yeast Research"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.00130-08","article-title":"Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan","volume":"15","author":"K Datta","year":"2008","journal-title":"Clinical and Vaccine Immunology"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.166.2.1087","article-title":"A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with <italic>Cryptococcus neoformans<\/italic> infection","volume":"166","author":"R Fleuridor","year":"2001","journal-title":"The Journal of Immunology"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1128\/IAI.66.6.2632-2639.1998","article-title":"Antigen-induced protective and nonprotective cell-mediated immune components against <italic>Cryptococcus neoformans<\/italic>","volume":"66","author":"JW Murphy","year":"1998","journal-title":"Infection and Immunity"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"e104316","DOI":"10.1371\/journal.pone.0104316","article-title":"Vaccine-mediated immune responses to experimental pulmonary <italic>Cryptococcus gattii<\/italic> infection in mice","volume":"9","author":"AK Chaturvedi","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing <italic>Cryptococcus neoformans<\/italic> strain","volume":"75","author":"FL Wormley","year":"2007","journal-title":"Infection and Immunity"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"e6854","DOI":"10.1371\/journal.pone.0006854","article-title":"Insights into the mechanisms of protective immunity against <italic>Cryptococcus neoformans<\/italic> infection using a mouse model of pulmonary cryptococcosis","volume":"4","author":"KL Wozniak","year":"2009","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00836","article-title":"Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of <italic>Cryptococcus neoformans<\/italic>: potential applications for vaccine development","volume":"6","author":"A Rella","year":"2015","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"e15572","DOI":"10.1371\/journal.pone.0015572","article-title":"Surface localization of glucosylceramide during <italic>Cryptococcus neoformans<\/italic> infection allows targeting as a potential anti-fungal","volume":"6","author":"RM Rhome","year":"2011","journal-title":"PLoS ONE"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1128\/IAI.68.12.7049-7060.2000","article-title":"Human antibodies against a purified glucosylceramide from <italic>Cryptococcus neoformans<\/italic> inhibit cell budding and fungal growth","volume":"68","author":"ML Rodrigues","year":"2000","journal-title":"Infection and Immunity"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.20011889","article-title":"Natural killer T cell ligand \u03b1-galactosylceramide enhances protective immunity induced by malaria vaccines","volume":"195","author":"G Gonzalez-Aseguinolaza","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11745-012-3666-1","article-title":"Beta-glucosylceramide administration (ip) activates natural killer T cells in vivo and prevents tumor metastasis in mice","volume":"47","author":"M Inafuku","year":"2012","journal-title":"Lipids"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI27890","article-title":"Glucosylceramide synthase is an essential regulator of pathogenicity of <italic>Cryptococcus neoformans<\/italic>","volume":"116","author":"PC Rittershaus","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1462-5822.2011.01735.x","article-title":"Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of <italic>Cryptococcus neoformans<\/italic>","volume":"14","author":"A Singh","year":"2012","journal-title":"Cellular Microbiology"},{"issue":"46","key":"ref19","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1021\/jf303117e","article-title":"Structural determination of glucosylceramides in the distillation remnants of shochu, the Japanese traditional liquor, and its production by <italic>Aspergillus kawachii<\/italic>","volume":"60","author":"M Hirata","year":"2012","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"e1003832","DOI":"10.1371\/journal.ppat.1003832","article-title":"Synthesis and biological properties of fungal glucosylceramide","volume":"10","author":"M Del Poeta","year":"2014","journal-title":"PLoS pathogens"},{"issue":"15","key":"ref21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2008.02.002","article-title":"Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, \u03b1-galactosylceramide","volume":"26","author":"Y Huang","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.4049\/jimmunol.175.5.3309","article-title":"\u03b1-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor","volume":"175","author":"S-Y Ko","year":"2005","journal-title":"The Journal of Immunology"},{"issue":"28","key":"ref23","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.vaccine.2009.03.090","article-title":"Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine","volume":"27","author":"SA Kopecky-Bromberg","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.175.3.1540","article-title":"\u03b1-Galactosylceramide-induced liver injury in mice is mediated by TNF-\u03b1 but independent of Kupffer cells","volume":"175","author":"M Biburger","year":"2005","journal-title":"The Journal of Immunology"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","article-title":"Evaluation of <italic>Cryptococcus neoformans<\/italic> galactoxylomannan\u2013protein conjugate as vaccine candidate against murine cryptococcosis","volume":"29","author":"S-K Chow","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/IAI.70.5.2383-2391.2002","article-title":"Identification and cloning of a cryptococcal deacetylase that produces protective immune responses","volume":"70","author":"C Biondo","year":"2002","journal-title":"Infection and Immunity"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00428-005-1265-8","article-title":"A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide\/d-galactosamine","volume":"446","author":"H Fujii","year":"2005","journal-title":"Virchows Archiv"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.4049\/jimmunol.166.11.6578","article-title":"Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by \u03b1-galactosylceramide in mice","volume":"166","author":"R Nakagawa","year":"2001","journal-title":"The Journal of Immunology"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/IAI.00587-07","article-title":"Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of <italic>Cryptococcus neoformans<\/italic> in immunodeficient mice","volume":"75","author":"TB Kechichian","year":"2007","journal-title":"Infection and Immunity"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(02)03067-3","article-title":"Disruption of the glucosylceramide biosynthetic pathway in <italic>Aspergillus nidulans<\/italic> and <italic>Aspergillus fumigatus<\/italic> by inhibitors of UDP-Glc: ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth","volume":"525","author":"SB Levery","year":"2002","journal-title":"FEBS Letters"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00253-005-0187-3","article-title":"Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast","volume":"71","author":"K Saito","year":"2006","journal-title":"Applied Microbiology and Biotechnology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/vaccines3010148","article-title":"Choice and design of adjuvants for parenteral and mucosal vaccines","volume":"3","author":"HFJ Savelkoul","year":"2015","journal-title":"Vaccines"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T19:07:40Z","timestamp":1600456060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153853"}},"subtitle":[],"editor":[{"given":"Michal A","family":"Olszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153853","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}